Cargando…

The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock

Corticosteroid treatment of severe sepsis has been one of the most controversial clinical issues in critical care. In fact, few agents can claim to have been evaluated in scores of studies spanning 3–4 decades. Yet, convincing proof that corticosteroids are useful pharmacologic agents in the treatme...

Descripción completa

Detalles Bibliográficos
Autor principal: Bernard, Gordon
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137314/
https://www.ncbi.nlm.nih.gov/pubmed/12398771
_version_ 1782120429655162880
author Bernard, Gordon
author_facet Bernard, Gordon
author_sort Bernard, Gordon
collection PubMed
description Corticosteroid treatment of severe sepsis has been one of the most controversial clinical issues in critical care. In fact, few agents can claim to have been evaluated in scores of studies spanning 3–4 decades. Yet, convincing proof that corticosteroids are useful pharmacologic agents in the treatment of this major clinical problem remains elusive. Recently, interest has resurfaced but this time the focus is on a steroid replacement approach for what has now been termed "relative adrenal insufficiency" rather than relying on the pharmacologic effects of steroids. This route holds promise, but proof remains lacking.
format Text
id pubmed-137314
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1373142003-02-27 The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock Bernard, Gordon Crit Care Commentary Corticosteroid treatment of severe sepsis has been one of the most controversial clinical issues in critical care. In fact, few agents can claim to have been evaluated in scores of studies spanning 3–4 decades. Yet, convincing proof that corticosteroids are useful pharmacologic agents in the treatment of this major clinical problem remains elusive. Recently, interest has resurfaced but this time the focus is on a steroid replacement approach for what has now been termed "relative adrenal insufficiency" rather than relying on the pharmacologic effects of steroids. This route holds promise, but proof remains lacking. BioMed Central 2002 2002-07-17 /pmc/articles/PMC137314/ /pubmed/12398771 Text en
spellingShingle Commentary
Bernard, Gordon
The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock
title The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock
title_full The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock
title_fullStr The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock
title_full_unstemmed The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock
title_short The International Sepsis Forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock
title_sort international sepsis forum's controversies in sepsis: corticosteroids should not be routinely used to treat septic shock
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137314/
https://www.ncbi.nlm.nih.gov/pubmed/12398771
work_keys_str_mv AT bernardgordon theinternationalsepsisforumscontroversiesinsepsiscorticosteroidsshouldnotberoutinelyusedtotreatsepticshock
AT bernardgordon internationalsepsisforumscontroversiesinsepsiscorticosteroidsshouldnotberoutinelyusedtotreatsepticshock